Last 7 days
-0.6%
Last 30 days
9.4%
Last 90 days
42.2%
Trailing 12 Months
-18.1%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 180.7B | 31.5B | -0.78% | -13.30% | 25.07 | 5.74 | 6.85% | 12.06% |
ABT | 171.9B | 43.7B | -4.52% | -15.68% | 24.79 | 3.94 | 1.34% | -1.95% |
MDT | 105.6B | 30.8B | -6.73% | -24.80% | 25.98 | 3.43 | -3.19% | -17.38% |
IDXX | 40.2B | 3.4B | 1.94% | -10.16% | 59.26 | 11.95 | 4.73% | -8.83% |
WST | 24.8B | 2.9B | 9.41% | -18.15% | 42.28 | 8.58 | 1.95% | -11.47% |
MID-CAP | ||||||||
PEN | 10.5B | 847.1M | 5.10% | 33.54% | -5.2K | 12.36 | 13.32% | -137.89% |
LNTH | 5.6B | 935.1M | 39.79% | 59.89% | 199.63 | 5.99 | 119.91% | 139.38% |
NEOG | 3.9B | 630.7M | -5.79% | -41.33% | -242.52 | 6.24 | 25.40% | -128.45% |
QDEL | 3.7B | - | -3.05% | -21.16% | 3.27 | 1.42 | - | - |
SMALL-CAP | ||||||||
VIVO | 1.5B | 301.6M | 2.29% | 56.91% | -550.1 | 4.93 | -3.75% | -104.51% |
CYRX | 1.1B | 237.3M | 15.32% | -32.47% | -24.23 | 4.63 | 6.59% | 84.02% |
HSKA | 958.4M | 257.3M | 13.67% | -32.65% | -48.19 | 3.72 | 1.41% | -1632.49% |
AWH | 51.1M | 7.9M | -14.38% | -62.64% | -1.65 | 6.49 | 23.02% | -7.81% |
QTNT | 766.7K | 37.4M | -50.00% | -99.61% | -0.01 | 0.02 | -2.49% | 10.49% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | -0.8% | 2,887 | 2,909 | 2,929 | 2,881 | 2,832 |
Gross Profit | -3.3% | 1,136 | 1,175 | 1,195 | 1,189 | 1,176 |
S&GA Expenses | -3.7% | 317 | 329 | 355 | 366 | 363 |
R&D Expenses | 3.9% | 59.00 | 56.00 | 56.00 | 55.00 | 53.00 |
EBITDA | -6.5% | 805 | 861 | 906 | 893 | - |
EBITDA Margin | -5.8% | 0.28* | 0.30* | 0.31* | 0.31* | - |
Earnings Before Taxes | -7.3% | 680 | 733 | 778 | 762 | 749 |
EBT Margin | -6.5% | 0.24* | 0.25* | 0.27* | 0.26* | - |
Interest Expenses | -10.2% | 8.00 | 9.00 | 8.00 | 9.00 | 8.00 |
Net Income | -7.1% | 586 | 631 | 686 | 684 | 662 |
Net Income Margin | -6.4% | 0.20* | 0.22* | 0.23* | 0.24* | - |
Free Cahsflow | 13.3% | 439 | 388 | 402 | 382 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 9.0% | 3,617 | 3,317 | 3,362 | 3,295 | 3,314 |
Current Assets | 10.7% | 1,920 | 1,734 | 1,771 | 1,691 | 1,742 |
Cash Equivalents | 22.7% | 894 | 729 | 719 | 668 | 763 |
Inventory | 0.4% | 415 | 413 | 412 | 417 | 378 |
Net PPE | 8.4% | 1,158 | 1,069 | 1,077 | 1,066 | 1,058 |
Goodwill | 3.2% | 107 | 104 | 107 | 109 | 110 |
Liabilities | 10.2% | 932 | 846 | 937 | 969 | 978 |
Current Liabilities | 13.6% | 519 | 457 | 565 | 585 | 594 |
Long Term Debt | -16.9% | 209 | 252 | 253 | 253 | - |
LT Debt, Current | -95.0% | 2.00 | 44.00 | 44.00 | 44.00 | - |
LT Debt, Non Current | -0.2% | 207 | 207 | 208 | 208 | 209 |
Shareholder's Equity | 8.7% | 2,685 | 2,471 | 2,424 | 2,326 | 2,335 |
Retained Earnings | 2.6% | 2,988 | 2,913 | 2,793 | 2,617 | 2,457 |
Additional Paid-In Capital | 0.7% | 232 | 231 | 225 | 220 | 249 |
Accumulated Depreciation | 5.5% | 1,228 | 1,164 | 1,169 | 1,171 | 1,158 |
Shares Outstanding | 0.1% | 74.00 | 74.00 | 74.00 | 74.00 | 74.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 10.7% | 724 | 654 | 675 | 647 | 584 |
Share Based Compensation | -12.2% | 24.00 | 27.00 | 32.00 | 37.00 | 38.00 |
Cashflow From Investing | -6.4% | -288 | -270 | -277 | -266 | -253 |
Cashflow From Financing | -1.1% | -293 | -290 | -220 | -184 | -168 |
Dividend Payments | 1.5% | 54.00 | 53.00 | 52.00 | 52.00 | 51.00 |
Buy Backs | 0.0% | 203 | 203 | 176 | 147 | 137 |
58.1%
18.5%
10.8%
Y-axis is the maximum loss one would have experienced if West Pharmaceutical Services was unfortunately bought at previous high price.
27.1%
26.8%
31.6%
35.3%
FIve years rolling returns for West Pharmaceutical Services.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | sold off | -100 | -228,000 | - | -% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -82.81 | -49,141,200 | 9,669,820 | 0.01% |
2023-03-10 | MATHER GROUP, LLC. | sold off | -100 | -249,000 | - | -% |
2023-03-10 | BAILLIE GIFFORD & CO | unchanged | - | -586 | 9,414 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -19.43 | -241,000 | 804,000 | -% |
2023-02-28 | Voya Investment Management LLC | added | 0.26 | -477,294 | 11,145,700 | 0.02% |
2023-02-24 | NATIXIS | added | 96.14 | 1,058,190 | 2,270,190 | 0.01% |
2023-02-24 | National Pension Service | added | 10.28 | 876,551 | 27,515,900 | 0.05% |
2023-02-24 | SRS Capital Advisors, Inc. | new | - | 99,082 | 99,082 | 0.01% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | -73,000 | 1,597,000 | 0.02% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | price t rowe associates inc /md/ | 3.1% | 2,301,161 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 12.14% | 8,988,409 | SC 13G/A | |
Jan 24, 2023 | blackrock inc. | 11.0% | 8,148,624 | SC 13G | |
Feb 14, 2022 | price t rowe associates inc /md/ | 8.4% | 6,241,901 | SC 13G/A | |
Feb 04, 2022 | franklin resources inc | 3.8% | 2,848,869 | SC 13G/A | |
Jan 27, 2022 | blackrock inc. | 10.9% | 8,094,288 | SC 13G/A | |
Jan 25, 2022 | blackrock inc. | 10.9% | 8,094,288 | SC 13G/A | |
Apr 12, 2021 | blackrock inc. | 10.1% | 7,467,809 | SC 13G/A | |
Feb 16, 2021 | price t rowe associates inc /md/ | 6.2% | 4,624,247 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 11.21% | 8,289,370 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 122.88 -63.24% | 150.44 -55.00% | 214.70 -35.78% | 298.78 -10.63% | 403.03 20.56% |
Current Inflation | 113.04 -66.19% | 136.41 -59.20% | 190.51 -43.01% | 260.94 -21.94% | 348.15 4.14% |
Very High Inflation | 100.93 -69.81% | 119.48 -64.26% | 162.06 -51.52% | 217.19 -35.03% | 285.37 -14.64% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 22, 2023 | 4 | Insider Trading | |
Mar 22, 2023 | 4 | Insider Trading | |
Mar 15, 2023 | ARS | ARS | |
Mar 15, 2023 | DEF 14A | DEF 14A | |
Mar 15, 2023 | DEFA14A | DEFA14A | |
Mar 09, 2023 | 4 | Insider Trading | |
Feb 23, 2023 | 4 | Insider Trading | |
Feb 23, 2023 | 4 | Insider Trading | |
Feb 23, 2023 | 4 | Insider Trading | |
Feb 23, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-09 | Abraham Silji | sold | -483,850 | 322 | -1,500 | svp, chief technology officer |
2023-03-07 | Green Eric Mark | sold | -14,183,500 | 322 | -44,000 | president & ceo |
2023-03-07 | Green Eric Mark | acquired | 2,869,000 | 57.38 | 50,000 | president & ceo |
2023-03-01 | Birkett Bernard | sold | -13,686 | 318 | -43.00 | sr vp, cfo & coo |
2023-03-01 | Abraham Silji | acquired | 74,477 | 318 | 234 | svp, chief technology officer |
2023-02-21 | Lai Quintin J | acquired | 347,775 | 306 | 1,134 | vp corp development & strategy |
2023-02-21 | Abraham Silji | acquired | 697,390 | 306 | 2,274 | chief digital & trans officer |
2023-02-21 | Witherspoon Charles | acquired | 124,819 | 306 | 407 | vp & treasurer |
2023-02-21 | Green Eric Mark | acquired | 4,533,650 | 306 | 14,783 | president & ceo |
2023-02-21 | Birkett Bernard | acquired | 1,108,340 | 306 | 3,614 | sr vp, cfo & coo |
CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Net sales | $ 2,886.9 | $ 2,831.6 | $ 2,146.9 |
Cost of goods and services sold | 1,750.7 | 1,655.8 | 1,379.1 |
Gross profit | 1,136.2 | 1,175.8 | 767.8 |
Research and development | 58.5 | 52.8 | 46.9 |
Selling, general and administrative expenses | 316.9 | 362.8 | 302.0 |
Other expense (income) (Note 16) | 26.8 | 7.9 | 12.0 |
Operating profit | 734.0 | 752.3 | 406.9 |
Interest expense | 7.9 | 8.2 | 8.2 |
Interest income | (5.1) | (1.0) | (1.4) |
Other nonoperating expense (income) | 51.3 | (3.8) | (1.2) |
Income before income taxes and equity in net income of affiliated companies | 679.9 | 748.9 | 401.3 |
Income tax expense | 114.7 | 107.2 | 72.5 |
Equity in net income of affiliated companies | (20.7) | (20.1) | (17.4) |
Net income | $ 585.9 | $ 661.8 | $ 346.2 |
Net income per share: | |||
Basic (in dollars per share) | $ 7.87 | $ 8.89 | $ 4.68 |
Diluted (in dollars per share) | $ 7.73 | $ 8.67 | $ 4.57 |
Weighted average shares outstanding: | |||
Basic (in shares) | 74.4 | 74.4 | 73.9 |
Diluted (in shares) | 75.8 | 76.3 | 75.8 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 894.3 | $ 762.6 |
Accounts receivable, net | 507.4 | 489.0 |
Inventories | 414.8 | 378.4 |
Other current assets | 103.0 | 112.0 |
Total current assets | 1,919.5 | 1,742.0 |
Property, plant and equipment | 2,386.6 | 2,215.0 |
Less: accumulated depreciation and amortization | 1,228.3 | 1,157.5 |
Property, plant and equipment, net | 1,158.3 | 1,057.5 |
Operating lease right-of-use assets | 104.4 | 69.3 |
Investments in affiliated companies | 204.9 | 207.7 |
Goodwill | 107.3 | 109.9 |
Intangible assets, net | 18.4 | 23.0 |
Deferred income taxes | 65.6 | 48.5 |
Pension and other postretirement benefits | 0.3 | 16.7 |
Other noncurrent assets | 38.1 | 39.2 |
Total Assets | 3,616.8 | 3,313.8 |
Current liabilities: | ||
Notes payable and other current debt | 2.2 | 44.2 |
Accounts payable | 215.4 | 232.2 |
Pension and other postretirement benefits | 2.1 | 2.4 |
Accrued salaries, wages and benefits | 76.8 | 116.3 |
Income taxes payable | 24.8 | 26.3 |
Operating lease liabilities | 16.0 | 9.3 |
Other current liabilities | 181.7 | 163.4 |
Total current liabilities | 519.0 | 594.1 |
Long-term debt | 206.7 | 208.8 |
Deferred income taxes | 14.3 | 4.9 |
Pension and other postretirement benefits | 28.2 | 40.5 |
Operating lease liabilities | 93.0 | 63.0 |
Deferred compensation benefits | 19.1 | 28.9 |
Other long-term liabilities | 51.6 | 38.2 |
Total Liabilities | 931.9 | 978.4 |
Commitments and contingencies (Note 18) | ||
Equity: | ||
Preferred stock, 3.0 million shares authorized; 0.0 shares issued and outstanding in 2022 and 2021 | 0.0 | 0.0 |
Common stock, par value $0.25 per share; 200 million shares authorized; shares issued: 75.3 million in 2022 and 2021; shares outstanding: 74.1 million and 74.2 million in 2022 and 2021 | 18.8 | 18.8 |
Capital in excess of par value | 232.2 | 249.0 |
Retained earnings | 2,987.8 | 2,456.7 |
Accumulated other comprehensive loss | (183.0) | (159.6) |
Treasury stock, at cost (1.2 million and 1.1 million shares in 2022 and 2021) | (370.9) | (229.5) |
Total Equity | 2,684.9 | 2,335.4 |
Total Liabilities and Equity | $ 3,616.8 | $ 3,313.8 |